Medical Device Shortage and Discontinuation Reporting: Your 2027 Plan

Health Canada has finalized a stronger framework for medical device shortages, and the reporting part of it arrives on a fixed date: 17 June 2027. If you manufacture or import medical devices in Canada, you now have a clear deadline to build toward, and a reporting process that looks different from the one your team may use today.

The amendments were published in the Canada Gazette, Part II on 17 June 2026 as a single instrument that covers both drugs and medical devices. The drug side of the same package is explained in our guide to Canada's new drug shortage regulations. For devices, some parts are already in force, while the shortage and discontinuation reporting changes come into force on 17 June 2027. This guide explains what changes, what you must report and when, who is exempt, and the practical steps to be ready well before the deadline.

Executive summary

The amended medical device shortage and discontinuation reporting requirements come into force on 17 June 2027, one year after publication. The related exceptional importation and foreign risk notification changes came into force earlier, on 17 June 2026. Health Canada has revised two guidance documents to match: the Guide to reporting and providing information on medical device shortages and discontinuations (GUI-0137) and the Guide on the exceptional importation and sale of medical devices in response to shortages (GUI-0147).

What to do now: confirm whether your products are specified medical devices, assign an owner for shortage and discontinuation monitoring, rewrite your reporting procedure to match the new calendar day timelines, and run a short drill so your team can report inside the five calendar day window. Treat the period to June 2027 as runway, not slack.

What is changing, and when it applies

What it is. The Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Shortages and Discontinuation of Sale of Drugs and Medical Devices) were published in the Canada Gazette, Part II, Volume 160, Number 12, on 17 June 2026. They strengthen and formalize the shortage framework for both drugs and medical devices.

Why it matters. The changes split into two in force dates. The exceptional importation and sale amendments, and the related foreign risk notification duty, came into force on 17 June 2026. The medical device shortage and discontinuation reporting amendments come into force on 17 June 2027. Until that date, the current shortage and discontinuation reporting requirements for medical devices stay the same, and the earlier guidance remains available for reference.

What to do. Put 17 June 2027 in your regulatory calendar now, and do not wait until spring 2027 to design the process. Read the revised GUI-0137 for reporting and GUI-0147 for exceptional importation, and confirm which of your devices are in scope before you build the workflow.

What you must report, and the new timelines

What it is. From 17 June 2027, reporting for specified medical devices changes in both method and timing. Regulated parties will publish required shortage information on a designated website rather than submitting it to Health Canada through online forms. The requirement to submit a summary explaining how a shortage was identified is removed. The exemption that applied to a manufacturer that also makes a substitute device is removed, so a substitute being available no longer avoids the duty to report.

Why it matters. The timelines move from business days to calendar days, which shortens the real time you have. A five calendar day clock can run across a weekend. Missing a window is a compliance gap that is easy for an inspector to see and hard to explain after the fact.

The reporting timelines at a glance.

Trigger	When you must report
Anticipated shortage identified more than 6 months before it starts	At least 6 months before the expected shortage start date
Anticipated shortage starting within 6 months or less	Within 5 calendar days of being identified
Discontinuation decided more than 12 months before the date	At least 12 months before the discontinuation date
Discontinuation dated within 12 months	Within 5 calendar days of the decision
Change to a discontinuation report, or new awareness of a change	Within 5 calendar days

What to do. Map each trigger to a step in your procedure, name who acts, and build the five calendar day response into your routine so it does not depend on one person being at their desk.

Discontinuations: report them even without a shortage

What it is. The amended rules require reporting of all discontinuations of specified medical devices, whether or not the discontinuation causes a shortage. Certain discontinuations are exempt when a compatible replacement can meet demand in Canada. The amendments also clarify that this shortage monitoring reporting is separate from the licence cancellation reporting you make under subsection 43(3) of the Medical Devices Regulations.

Why it matters. Teams that only report when a shortage is obvious will miss discontinuations that must be reported on their own. The twelve month and five calendar day discontinuation clocks need a decision point in your product lifecycle process, not a reaction after the fact.

What to do. Add a discontinuation check to your product end of life and portfolio decisions. Before you rely on the compatible replacement exemption, document why the replacement can meet Canadian demand, and keep that rationale on file.

Who is exempt, and who can report for whom

What it is. The amendments ease the burden in two helpful ways. Importers that are retailers, and health care facilities that distribute devices only within their own facility, are exempt from shortage reporting. Importers may report shortages and discontinuations on behalf of manufacturers, for all device classes.

Why it matters. This flexibility lets a Canadian importer act as the single reporting point for a foreign manufacturer, which is often the most practical arrangement. It also means you need a clear agreement about who reports, so a shortage does not go unreported because each party assumed the other would act.

What to do. Decide in writing, with each manufacturer you import for, who will file shortage and discontinuation reports. If you hold a Medical Device Establishment Licence, align this with your other duties, and see our guide to the Phase 2 MDEL amendments and the new online form.

Exceptional importation of devices is already in force

What it is. The exceptional importation and sale amendments came into force on 17 June 2026. They clarify that a device can be added to the List of Medical Devices for Exceptional Importation and Sale when an actual or anticipated shortage could present a risk of injury to human health. They set the advance notice for establishment licence holders at at least 3 business days before importing a designated device, and they require importers to notify Health Canada of communicated risks in foreign jurisdictions, such as a foreign recall, that could affect the safety or effectiveness of a listed device.

Why it matters. Exceptional importation is how Canada keeps a needed device available during a shortage, but it comes with notice and vigilance duties that are live today. We covered the shortened notice window in detail in our guide to the 3 business day exceptional importation notification.

What to do. If you may import under the exceptional pathway, build the 3 business day notice into your import process now, and set up a way to catch and report foreign risk signals for any listed device you handle.

What counts as a specified medical device

What it is. The shortage and discontinuation reporting duties apply to specified medical devices, the category the Medical Devices Regulations use to define the scope of the shortage framework. The amended rules refine that scope and align the device framework more closely with the drug framework.

Why it matters. Scope decides whether a duty applies to your product at all. Treating an in scope device as out of scope, or the reverse, leads to either a missed report or wasted effort.

What to do. Confirm whether each of your products is a specified medical device against the current Medical Devices Regulations and Health Canada guidance before you rely on being in or out of scope. If you are not certain, treat the product as in scope until you have confirmed otherwise, and seek advice where the classification is unclear.

A practical example

Consider a Canadian importer of a Class II infusion related device whose foreign manufacturer plans to stop making one model. The manufacturer tells the importer in March 2028 that production will end in February 2029, about eleven months out. Under the amended rules, that discontinuation sits inside the twelve month window, so it must be reported within five calendar days of the decision, not twelve months ahead. Because the importer agreed in advance to report on the manufacturer's behalf, and had a procedure that treats any discontinuation notice as a five day clock, the report goes out on time. A team without that agreement and procedure could lose the window while deciding who was responsible.

Medical device shortage reporting readiness checklist

Scope confirmed: you know which of your products are specified medical devices in scope of the reporting framework.
Owner named: a person and backup own shortage and discontinuation monitoring, reporting and records.
Timelines built in: your procedure maps the six month, twelve month and five calendar day triggers to specific steps.
Designated website ready: your team knows how to publish required information on the designated website from 17 June 2027.
Discontinuation check added: product end of life decisions trigger a discontinuation report check, with the exemption rationale documented when used.
Reporting responsibility agreed: you have written agreement with each manufacturer on who reports shortages and discontinuations.
Exceptional importation ready: the 3 business day notice and foreign risk notification steps are in place today.
Records kept: you can show when each shortage or discontinuation was identified, decided and reported.

Common mistakes to avoid

Waiting until 2027 to start. The reporting process needs design, SOPs and a drill. The runway is the point of the one year lead time.
Counting in business days. The new timelines use calendar days, so a five day clock can run through a weekend.
Reporting only shortages. All discontinuations of specified devices must be reported, whether or not a shortage results.
Assuming a substitute device avoids the duty. The exemption for a manufacturer that also makes a substitute device is removed.
Leaving reporting responsibility unclear. If importer and manufacturer each assume the other reports, the report may never be filed.
Confusing this with recall reporting. Shortage reporting is separate from recall duties and from licence cancellation under subsection 43(3). Our guide to medical device recall reporting explains the recall side.

Frequently asked questions

When do the new medical device shortage reporting rules take effect?

The amended medical device shortage and discontinuation reporting requirements come into force on 17 June 2027, one year after publication in the Canada Gazette, Part II. The related exceptional importation and foreign risk notification changes came into force earlier, on 17 June 2026.

Who must report a medical device shortage in Canada?

Manufacturers and importers of specified medical devices. Importers may report on behalf of manufacturers for all device classes. Importers that are retailers, and health care facilities that distribute devices only within their own facility, are exempt from shortage reporting.

What are the new reporting timelines?

An anticipated shortage seen more than six months ahead must be reported at least six months before the expected start date. A shortage starting within six months must be reported within five calendar days of being identified. A discontinuation decided more than twelve months ahead must be reported at least twelve months before the date, and a nearer one within five calendar days. Updates to a discontinuation report are due within five calendar days.

Do I have to report a discontinuation even if there is no shortage?

Yes. All discontinuations of specified medical devices must be reported, whether or not they cause a shortage. Certain discontinuations are exempt when a compatible replacement can meet demand in Canada, and you should document the basis for any exemption you rely on.

What is a specified medical device?

It is the category of device to which the shortage and discontinuation reporting framework in the Medical Devices Regulations applies. Confirm whether your specific products are in scope with Health Canada and the current regulations before relying on an exemption.

How is this different from recall or licence cancellation reporting?

Shortage and discontinuation reporting is separate from recall reporting and from licence cancellation reporting under subsection 43(3) of the Medical Devices Regulations. You can carry duties under more than one of these at the same time, so keep them as distinct processes.

How MFLRC can help

MFLRC helps device manufacturers and importers turn the 17 June 2027 deadline into a working process. We confirm which of your products are in scope, write or update your shortage and discontinuation reporting SOPs to match the new calendar day timelines, and set up the monitoring and records that make reporting routine. Our regulatory affairs and quality assurance teams support MDEL applications and amendments, gap assessments, supplier qualification, mock recall and shortage drills, exceptional importation readiness, and inspection readiness, so your framework reflects how you actually operate.

If you want your reporting process designed and tested before June 2027, we can help you plan the work backward from the date and close the gaps first.

Book a consultation

Conclusion

The amended framework gives medical device makers and importers something useful: a fixed date and a clear set of duties. From 17 June 2027, reporting for specified medical devices moves to calendar day timelines and a designated website, discontinuations must be reported whether or not they cause a shortage, and the substitute device exemption is gone. The exceptional importation and foreign risk duties are already live. Confirm your scope, name an owner, write the procedure and run a drill, and the deadline becomes a date you meet rather than a scramble you survive.